The rise of Ozempic: how surprise discoveries and lizard venom led to a new class of weight-loss drugs

Ozempic generated A$21bn of sales in 2023 alone. So how was it developed? And how are its new competitors, Mounjaro and Zepbound, different?

Related Keywords

, Novo Nordisk , Sebastian Furness ,